CMS Ends Reimbursement for TENS Treatment
In a memo released Friday and effectively immediately, CMS officials wrote that reimbursement for TENS for low back pain will be available only when patients are participating in a randomized, controlled trial to gauge the clinical effectiveness of the treatment.
"TENS is not reasonable and necessary for the treatment of [chronic low back pain]," the memo said. "Long-standing use of a medical treatment is unfortunately no guarantee that it is in fact clinically appropriate or necessary."
Medicare previously paid for FDA-approved TENS equipment and supplies when prescribed by a physician for chronic pain and reimbursed physicians and physical therapists for evaluating patients' suitability for the treatment.
Related Articles on Pain Management:
Post-Operative Pain Drug Yields Positive Trial ResultsMallinckrodt and Zogenix to Collaborate on Migraine Treatment
50 Pain Management Physician Medical Directors
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.